| 2026 |
Fraser, L., Wiese, M. D., Ailabouni, N., Ellett, L. K., Sirois, C., Berthelot, W., . . . Reeve, E. (2026). Patients’ attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis. Patient Education and Counseling, 143(109432), 109432.
DOI |
| 2025 |
Langford, A. V., Warriach, I., McEvoy, A. M., Karaim, E., Chand, S., Turner, J. P., . . . Reeve, E. (2025). What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Quality and Safety, 34(1), 017101-1-017101-12.
DOI Scopus19 WoS21 Europe PMC17 |
| 2025 |
Law, R., Gupta, N., Langford, A. V., & Reeve, E. (2025). Attitudes of Australian patients receiving inpatient mental health care towards deprescribing: a cross-sectional survey. BMC Psychiatry, 25(1, article no. 269), 1-11.
DOI Scopus1 |
| 2025 |
Reeve, E., Cowan, K., Kalisch Ellett, L., Sinclair, R., Nguyen, T. A., Sluggett, J. K., & Ailabouni, N. (2025). Top 10 consumer and healthcare professional priorities for research in the field of quality use of medicines in people living with dementia. Journal of Alzheimer's Disease, 107(1), 207-222.
DOI |
| 2025 |
Wallis, J. A., Langford, A. V., O'Connor, D., Reeve, E., Ackerman, I. N., Haas, R., . . . Buchbinder, R. (2025). Implementation interventions to promote healthcare professional uptake of evidence-based opioid prescribing for adults with acute non-cancer pain. Cochrane Database of Systematic Reviews, 2025(7), CD016179.
DOI |
| 2025 |
Fraser, L., Ailabouni, N., Ellett, L. K., Tan, J. M., Freeman, A., Proudman, S. M., . . . Wiese, M. D. (2025). A scoping review of disease-modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice. British Journal of Clinical Pharmacology, online(12), 1-11.
DOI Europe PMC1 |
| 2025 |
Mellors, D., Antonas, D., Russell, P., Arunasalam, H., Ailabouni, N., Koeper, I., & Reeve, E. (2025). Hospital readmissions related to adverse drug withdrawal events in older adults: a pilot study. International Journal Of Clinical Pharmacy, online, 1-17.
DOI |
| 2025 |
Tan, J. M., Desforges, K., Chai, W. C., Proudman, S. M., Wiese, M. D., & Reeve, E. (2025). Perspectives of patients with rheumatoid arthritis towards the use of parenteral methotrexate: a qualitative study. International Journal Of Clinical Pharmacy, online, 1-12.
DOI Europe PMC1 |
| 2025 |
Mehta, H. B., Sekhon, V. K., Reeve, E., Sheehan, O. C., Boyd, C. M., & Green, A. R. (2025). Exploring the association between intention and action in deprescribing. Journal of the American Geriatrics Society, 73(4), 1297-1300.
DOI |
| 2025 |
Fried, T. R., Ouyang, N., Gnjidic, D., Green, A., Hilmer, S., Holmes, H. M., . . . Funaro, M. C. (2025). Communication as a key component of deprescribing: conceptual framework and review of the literature. Journal of the American Geriatrics Society, 73(3), 717-727.
DOI |
| 2025 |
Maher, D., Reeve, E., & Wiese, M. (2025). Reply. Arthritis Care and Research, 77(7), 939-940.
DOI |
| 2025 |
Gnjidic, D., Langford, A. V., Jordan, V., Sawan, M., Sheppard, J. P., Thompson, W., . . . Reeve, E. (2025). Withdrawal of antihypertensive drugs in older people. Cochrane Database of Systematic Reviews, 2025(3), 1-66.
DOI |
| 2025 |
Lord, L., Langford, A., Wang, T., Shaw, G., Ilomaki, J., Reeve, E., & Turner, J. (2025). Barriers and enablers to deprescribing for people living with cystic fibrosis: multidisciplinary perspectives. Respiratory Medicine, 242(108091), 1-7.
DOI |
| 2025 |
Goordeen, D., Bell, J. S., Elsedfy, Y., Fariman, S., Hamada, S., Hattori, Y., . . . Reeve, E. (2025). Diabetes medication management recommendations for older adults: a systematic review of the Western Pacific region. Geriatrics and Gerontology International, 25(6), 717-729.
DOI |
| 2025 |
Bayliss, E. A., Goodrich, G. K., Barrow, J. C., Harding, B., Ripley, C. A., Kraus, C. R., . . . Boyd, C. M. (2025). Discontinuation categories underlying gaps in dispensing for six medication groups. Pharmacoepidemiology and Drug Safety, 34(4), 1-10.
DOI Scopus3 WoS3 Europe PMC3 |
| 2025 |
McEvoy, A. M., Langford, A. V., Liau, S. J., Goordeen, D., Reeve, E., & Turner, J. P. (2025). Deprescribing Benzodiazepine receptor agonists in older adults and people with cognitive impairment: a systematic review. Journal of the American Geriatrics Society, online(9), 1-9.
DOI |
| 2025 |
Vidonscky Luethold, R., Jungo, K. T., Weir, K. R., Adler, L., Reeve, E., & Streit, S. (2025). Older adults' attitudes toward deprescribing in 14 Countries. Jama Network Open, 8(2), 1-15.
DOI |
| 2025 |
Langford, A. V., Wallis, J. A., Reeve, E., Buchbinder, R., Cross, A. J., Turner, J., . . . O'Connor, D. (2025). Implementation interventions to promote healthcare professional uptake of evidence-based opioid deprescribing for adults with chronic non-cancer pain. Cochrane Database of Systematic Reviews, 2025(7), CD016178.
DOI |
| 2024 |
Lim, A., Abeyaratne, C., Reeve, E., Desforges, K., & Malone, D. (2024). Using Kane's validity framework to compare an integrated and single-skill objective structured clinical examination. American Journal of Pharmaceutical Education, 88(9, article no. 100756), 1-6.
DOI |
| 2024 |
Chua, S., Todd, A., Reeve, E., Smith, S. M., Fox, J., Elsisi, Z., . . . Gray, S. L. (2024). Deprescribing interventions in older adults: An overview of systematic reviews. PLoS ONE, 19(6, article no. e0305215), 1-20.
DOI Scopus9 WoS10 Europe PMC10 |
| 2024 |
Ailabouni, N. J., Weir, K. R., Brandt, N., Hanjani, L. S., Green, A., Thompson, W., . . . Reeve, E. (2024). Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool: reflections and recommendations. Basic & Clinical Pharmacology & Toxicology, 134(1), 121-125.
DOI |
| 2024 |
Boyd, C. M., Shetterly, S. M., Powers, J. D., Weffald, L. A., Green, A. R., Sheehan, O. C., . . . Bayliss, E. A. (2024). Evaluating the safety of an educational deprescribing intervention: lessons from the optimize trial. Drugs and Aging, 41(1), 45-54.
DOI Scopus8 WoS8 Europe PMC7 |
| 2024 |
Langford, A. V., Bero, L., Lin, C. W. C., Blyth, F. M., Doctor, J. N., Holliday, S., . . . Schneider, C. R. (2024). Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. Journal of Clinical Epidemiology, 165(111204), 1-10.
DOI Scopus5 WoS4 Europe PMC4 |
| 2024 |
Langford, A. V., Schneider, C. R., Reeve, E., Doctor, J. N., & Gnjidic, D. (2024). Comment on: 'Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing'. Drugs and Aging, 41(1), 77-78.
DOI |
| 2024 |
McDonald, E. G., Lundby, C., Thompson, W., Boyd, C., Farrell, B., Gagnon, C., . . . Reeve, E. (2024). Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks. Expert Review of Clinical Pharmacology, 17(5-6), 433-440.
DOI Europe PMC2 |
| 2024 |
Reeve, E., Gnjidic, D., Langford, A. V., & Hilmer, S. N. (2024). Deprescribing antihypertensive drugs in frail older adults. Australian Prescriber, 47(3), 85-90.
DOI |
| 2024 |
Ailabouni, N. J., Thompson, W., Hilmer, S. N., Quirke, L., McNeece, J., Bourke, A., . . . Reeve, E. (2024). Co-designing a consult patient decision aid for continuation versus deprescribing cholinesterase inhibitors in people living with dementia. Drugs and Aging, 41(10), 821-831.
DOI |
| 2024 |
Langford, A. V., Schneider, C. R., Reeve, E., & Gnjidic, D. (2024). Minimising harm and managing pain: deprescribing Opioids in older adults. Drugs and Aging, 41(11), 863-871.
DOI |
| 2024 |
Maher, D., Reeve, E., Hopkins, A., Tan, J. M., Tantiongco, M., Ailabouni, N., . . . Wiese, M. (2024). Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis. Arthritis Care and Research, 76(6), 871-881.
DOI Scopus7 WoS7 Europe PMC2 |
| 2024 |
Dowd, L. A., Hamada, S., Hattori, Y., Veal, F. C., Taguchi, R., Sakata, N., . . . Cross, A. J. (2024). A mixed-methods study on the pharmacological management of pain in Australian and Japanese nursing homes. Age and Ageing, 53(2), afae024-1-afae024-13.
DOI Scopus5 WoS4 Europe PMC4 |
| 2023 |
Tan, J. M., Reeve, E., Fraser, L., Proudman, S. M., & Wiese, M. D. (2023). The Barriers and Enablers to the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care and Research, 75(11), 2306-2315.
DOI Scopus2 WoS2 Europe PMC2 |
| 2023 |
Norton, J. D., Zeng, C., Bayliss, E. A., Shetterly, S. M., Williams, N., Reeve, E., . . . Boyd, C. M. (2023). Ethical aspects of physician decision-making for deprescribing among older adults with dementia. JAMA network open, 6(10), 1-14.
DOI Scopus7 WoS7 Europe PMC6 |
| 2023 |
Reeve, E., Chenoweth, L., Sawan, M., Nguyen, T. A., Kalisch Ellett, L., Gilmartin-Thomas, J., . . . Hilmer, S. N. (2023). Consumer and Healthcare Professional Led Priority Setting for Quality Use of Medicines in People with Dementia: Gathering Unanswered Research Questions. Journal of Alzheimer S Disease, 91(3), 933-960.
DOI Scopus6 WoS5 Europe PMC4 |
| 2023 |
Sheehan, O. C., Gleason, K. S., Bayliss, E. A., Green, A. R., Drace, M. L., Norton, J., . . . Boyd, C. M. (2023). Intervention design in cognitively impaired populations-lessons learned from the OPTIMIZE deprescribing pragmatic trial. Journal Of The American Geriatrics Society, 71(3), 774-784.
DOI Scopus6 WoS8 Europe PMC6 |
| 2023 |
Reeve, E., Bayliss, E. A., Shetterly, S., Maiyani, M., Gleason, K. S., Norton, J. D., . . . Boyd, C. M. (2023). Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age and ageing, 52(1), 1-9.
DOI Scopus11 WoS10 Europe PMC10 |
| 2023 |
Reeve, E., Thompson, W., Boyd, C., Lundby, C., & Steinman, M. A. (2023). The state of deprescribing research: how did we get here?. Basic & Clinical Pharmacology & Toxicology, 133(6), 657-660.
DOI Europe PMC6 |
| 2023 |
Thompson, W., Reeve, E., McDonald, E. G., Farrell, B., Scott, S., Steinman, M. A., . . . Lundby, C. (2023). Ten deprescribing articles you should know about: a guide for newcomers to the field. Basic & Clinical Pharmacology & Toxicology, 133(6), 661-664.
DOI |
| 2023 |
Fujita, K., Hooper, P., Masnoon, N., Lo, S., Gnjidic, D., Etherton Beer, C., . . . Hilmer, S. N. (2023). Impact of a comprehensive intervention bundle including the drug burden index on deprescribing anticholinergic and sedative drugs in older acute inpatients: a non-randomised controlled before-and-after pilot study. Drugs and Aging, 40(7), 633-642.
DOI |
| 2023 |
Langford, A. V., Lin, C. C. W., Bero, L., Blyth, F. M., Doctor, J., Holliday, S., . . . Gnjidic, D. (2023). Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Medical Journal of Australia, 219(2), 80-88.
DOI Scopus42 WoS37 Europe PMC29 |
| 2023 |
Bucsa, C., Onea, M., Rusu, A., Farcas, A., Porojan, M., Dumitrascu, D., . . . Moga, D. (2023). Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults. Research in Social and Administrative Pharmacy, 19(11), 1471-1479.
DOI |
| 2023 |
Spinewine, A., Reeve, E., & Thompson, W. (2023). Revisiting systematic reviews on deprescribing trials to better inform future practice and research. British Journal of Clinical Pharmacology, 89(12), 3758-3764.
DOI |
| 2022 |
Ailabouni, N. J., Weir, K. R., Reeve, E., Turner, J. T., Wilson Norton, J., & Gray, S. L. (2022). Barriers and enablers of older adults initiating a deprescribing conversation. Patient Education and Counseling, 105(3), 615-624.
DOI |
| 2022 |
Weir, K. R., Ailabouni, N. J., Schneider, C. R., Hilmer, S. N., & Reeve, E. (2022). Considerations for systematic reviews of quantitative surveys: learnings from a systematic review of the patients' attitudes towards deprescribing questionnaire. Research in Social and Administrative Pharmacy, 18(2), 2345-2349.
DOI |
| 2022 |
Bai, I., Isenor, J. E., Reeve, E., Whelan, A. M., Martin Misener, R., Burgess, S., & Kennie Kaulbach, N. (2022). Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs. Research in Social and Administrative Pharmacy, 18(8), 3350-3357.
DOI |
| 2022 |
Bayliss, E. A., Shetterly, S. M., Drace, M. L., Norton, J. D., Maiyani, M., Gleason, K. S., . . . Boyd, C. M. (2022). Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: the OPTIMIZE pragmatic cluster randomized trial. JAMA Internal Medicine, 182(5), 534-542.
DOI Scopus67 WoS67 Europe PMC68 |
| 2022 |
Shrestha, S., Poudel, A., Reeve, E., Linsky, A. M., Steadman, K. J., & Nissen, L. M. (2022). Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy. Research In Social & Administrative Pharmacy, 18(9), 3596-3601.
DOI |
| 2022 |
Scott, I. A., Reeve, E., & Hilmer, S. N. (2022). Establishing the worth of deprescribing inappropriate medications: are we there yet?. Medical Journal of Australia, 217(6), 283-286.
DOI |
| 2022 |
Gnjidic, D., Johansson, M., Meng, D. M., Farrell, B., Langford, A., & Reeve, E. (2022). Achieving sustainable healthcare through deprescribing. The Cochrane database of systematic reviews, 10(10), 1-3.
DOI |
| 2022 |
Turner, J. P., Thompson, W., Reeve, E., & Bell, J. S. (2022). Deprescribing proton pump inhibitors. Australian journal of general practice, 51(11), 845-848.
DOI |
| 2022 |
Thompson, W., & Reeve, E. (2022). Deprescribing: moving beyond barriers and facilitators. Research in Social and Administrative Pharmacy, 18(3), 2547-2549.
DOI |
| 2022 |
Ailabouni, N. J., Reeve, E., Helfrich, C. D., Hilmer, S. N., & Wagenaar, B. H. (2022). Leveraging implementation science to increase the translation of deprescribing evidence into practice. Research in Social and Administrative Pharmacy, 18(3), 2550-2555.
DOI |
| 2022 |
Weir, K. R., Ailabouni, N. J., Schneider, C. R., Hilmer, S. N., & Reeve, E. (2022). Consumer attitudes towards deprescribing: a systematic review and meta-analysis. The journals of gerontology. Series A, Biological sciences and medical sciences, 77(5), 1020-1034.
DOI |
| 2022 |
Kouladjian O'Donnell, L., Reeve, E., & Hilmer, S. N. (2022). Development, validation and evaluation of the goal-directed medication review electronic decision support system (G-MEDSS)©. Research in Social and Administrative Pharmacy, 18(7), 3174-3183.
DOI |
| 2022 |
Kennie Kaulbach, N., Kehoe, S., Whelan, A. M., Reeve, E., Bai, I., Burgess, S., . . . Isenor, J. E. (2022). Use of a knowledge exchange event strategy to identify key priorities for implementing deprescribing in primary healthcare in Nova Scotia, Canada. Evidence and Policy, 18(3), 619-630.
DOI |
| 2022 |
White, A., Fulda, K. G., Blythe, R., Chui, M. A., Reeve, E., Young, R., . . . Xiao, Y. (2022). Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety. Expert Opinion on Drug Safety, 21(11), 1357-1364.
DOI WoS16 Europe PMC13 |
| 2021 |
Jungo, K. T., Mantelli, S., Rozsnyai, Z., Missiou, A., Reeve, E., & Streit, S. (2021). General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries. BMC Geriatrics, 21(1, article no. 19), 1-12.
DOI Scopus32 WoS32 Europe PMC30 |
| 2021 |
Ailabouni, N. J., Hilmer, S. N., Kalisch, L., Braund, R., & Reeve, E. (2021). COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(6), 1068-1073.
DOI Scopus17 WoS15 Europe PMC18 |
| 2021 |
Green, A. R., Boyd, C. M., Gleason, K. S., Wright, L., Kraus, C. R., Bedoy, R., . . . Bayliss, E. A. (2021). Perspectives on Deprescribing Communication in Primary Care. Journal of General Internal Medicine, 36(4), 1122.
DOI Scopus3 WoS3 Europe PMC3 |
| 2021 |
Jungo, K. T., Meier, R., Valeri, F., Schwab, N., Schneider, C., Reeve, E., . . . Streit, S. (2021). Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial. BMC Family Practice, 22(article number: 123), 1-14.
DOI |
| 2021 |
Lo, S. Y., Reeve, E., Page, A. T., Zaidi, S. T. R., Hilmer, S. N., Etherton Beer, C., . . . Naganathan, V. (2021). Attitudes to drug use in residential aged care facilities: a cross-sectional survey of nurses and care staff. Drugs and Aging, 38(8), 697-711.
DOI |
| 2021 |
Sawan, M., Kouladjian O'Donnell, L., Reeve, E., Gnjidic, D., Chen, T. F., Kelly, P. J., . . . Hilmer, S. N. (2021). The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation. Research in Social and Administrative Pharmacy, 17(4), 715-722.
DOI Scopus13 Europe PMC9 |
| 2021 |
Kouladjian O'Donnell, L., Gnjidic, D., Sawan, M., Reeve, E., Kelly, P. J., Chen, T. F., . . . Hilmer, S. N. (2021). Impact of the Goal‐directed Medication review Electronic Decision Support System (G‐MEDSS)© on Drug Burden Index: a cluster‐randomised clinical trial in primary care. British Journal of Clinical Pharmacology, 87(3), 1499-1511.
DOI Scopus33 Europe PMC30 |
| 2021 |
Isenor, J. E., Bai, I., Cormier, R., Helwig, M., Reeve, E., Whelan, A. M., . . . Kennie Kaulbach, N. (2021). Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: a scoping review. Research in Social and Administrative Pharmacy, 17(7), 1229-1241.
DOI |
| 2021 |
Maher, D., Ailabouni, N., Mangoni, A. A., Wiese, M. D., & Reeve, E. (2021). Alterations in drug disposition in older adults: a focus on geriatric syndromes. Expert Opinion on Drug Metabolism & Toxicology, 17(1), 41-52.
DOI |
| 2021 |
Roux, B., Sirois, C., Niquille, A., Spinewine, A., Ouellet, N., Petein, C., . . . Reeve, E. (2021). Cross-cultural adaptation and psychometric validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in French. Research in Social and Administrative Pharmacy, 17(8), 1453-1462.
DOI |
| 2021 |
Kouladjian O'Donnell, L., Reeve, E., Cumming, A., Scott, I. A., & Hilmer, S. N. (2021). Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians. Internal Medicine Journal, 51(1), 111-115.
DOI |
| 2021 |
Reeve, E. (2021). Consideration of frailty versus limited life expectancy when deprescribing: a response to: 'LESS CHRON: a tool for deprescribing in patients with multimorbidity'. Journal of Pharmacy Practice and Research, 51(2), 185-186.
DOI |
| 2021 |
Kua, C. H., Reeve, E., Tan, D. S. Y., Koh, T., Soong, J. L., Sim, M. J. L., . . . Lee, S. W. H. (2021). Patients' and caregivers' attitudes towards deprescribing in Singapore. The Journals of Gerontology: Series A Biological Science and Medical Sciences, 76(6), 1053-1060.
DOI |
| 2020 |
Rozsnyai, Z., Jungo, K. T., Reeve, E., Poortvliet, R. K. E., Rodondi, N., Gussekloo, J., & Streit, S. (2020). What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey. BMC Geriatrics, 20(435), 1-11.
DOI |
| 2020 |
Achterhof, A. B., Rozsnyai, Z., Reeve, E., Jungo, K. T., Floriani, C., Poortvliet, R. K. E., . . . Streit, S. (2020). Potentially inappropriate medication and attitudes of older adults towards deprescribing. PLoS ONE, 15(10, article no. e0240463), 1-14.
DOI |
| 2020 |
Bayliss, E. A., Shetterly, S. M., Drace, M. L., Norton, J., Green, A. R., Reeve, E., . . . Boyd, C. M. (2020). The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials, 21(1, article no. 542,), 1-13.
DOI Scopus31 WoS25 Europe PMC26 |
| 2020 |
D'Avanzo, B., Agosti, P., Reeve, E., Pasina, L., Sabbà, C., Mannucci, P. M., & Nobili, A. (2020). Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study. Maturitas, 134, 29-33.
DOI |
| 2020 |
Green, A., Boyd, C. M., Gleason, K. S., Wright, L., Kraus, C. R., Bedoy, R., . . . Bayliss, E. A. (2020). Designing a primary care-based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study. Journal of General Internal Medicine, 35(12), 3556-3563.
DOI Scopus37 WoS37 Europe PMC35 |
| 2020 |
Kennie Kaulbach, N., Cormier, R., Kits, O., Reeve, E., Whelan, A. M., Martin Misener, R., . . . Isenor, J. E. (2020). Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks. Medicine Access @ Point of Care, 4, 1-12.
DOI |
| 2020 |
Gnjidic, D., & Reeve, E. (2020). Deprescribing: what do we know, and where to next?. British Journal of Clinical Pharmacology, 87(3), 722-724.
DOI |
| 2020 |
O'Donnell, L. K., Sawan, M., Reeve, E., Gnjidic, D., Chen, T. F., Kelly, P. J., . . . Hilmer, S. N. (2020). Erratum: Correction to: Implementation of the goal-directed medication review electronic decision support system (G-MEDSS)© into home medicines review: a protocol for a clusterrandomised clinical trial in older adults (BMC geriatrics (2020) 20 1 (51)). BMC Geriatrics, 20(1), 378.
DOI Europe PMC1 |
| 2020 |
Dearing, M. E., Bowles, S. K., Isenor, J. E., Theou, O., & Reeve, E. (2020). Medication-related criteria in frailty assessment tools: a narrative review. Australasian Journal on Ageing, 39(3), e640-e465.
DOI |
| 2020 |
Reeve, E. (2020). Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice. Journal of Pharmacy Practice and Research, 50(1), 98-107.
DOI |
| 2020 |
Kouladjian O'Donnell, L., Sawan, M., Reeve, E., Gnjidic, D., Chen, T. F., Kelly, P. J., . . . Hilmer, S. N. (2020). Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults. BMC geriatrics, 20(1), 1-12.
DOI Scopus16 Europe PMC11 |
| 2020 |
Sawan, M., Reeve, E., Turner, J., Todd, A., Steinman, M. A., Petrovic, M., & Gnjidic, D. (2020). A systems approach to identifying the challenges of implementing deprescribing in older adults across different health care settings and countries: a narrative review. Expert Review of Clinical Pharmacology, 13(3), 233-245.
DOI Europe PMC71 |
| 2020 |
Dearing, M. E., Bowles, S., Isenor, J., Kits, O., Kouladjian O'Donnell, L., Neville, H., . . . Reeve, E. (2020). Pharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysis. BMJ open, 10(2), e035656.
DOI |
| 2020 |
Martinez, A. I., Spencer, J., Moloney, M., Badour, C., Reeve, E., & Moga, D. C. (2020). Attitudes toward deprescribing in a middle-aged health disparities population. Research in Social and Administrative Pharmacy, 16(10), 1502-1507.
DOI |
| 2019 |
Green, A. R., Lee, P., Reeve, E., Wolff, J. L., Chen, C. C. G., Kruzan, R., & Boyd, C. M. (2019). Clinicians' perspectives on barriers and enablers of optimal prescribing in patients with dementia and coexisting conditions. Journal of the American Board of Family Medicine, 32(3), 383-391.
DOI |
| 2019 |
Gnjidic, D., Ong, H. M. M., Leung, C., Jansen, J., & Reeve, E. (2019). The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study. Therapeutic advances in drug safety, 10, 1-11.
DOI |
| 2019 |
Reeve, E., Low, L. F., & Hilmer, S. N. (2019). Attitudes of older adults and caregivers in Australia toward deprescribing. Journal of the American Geriatrics Society, 67(6), 12041.
DOI |
| 2019 |
Farrell, B., Conklin, J., Dolovich, L., Irving, H., Maclure, M., McCarthy, L., . . . Thompson, W. (2019). Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Research in social and administrative pharmacy, 15(6), 780-789.
DOI |
| 2019 |
Thompson, W., Reeve, E., Moriarty, F., Maclure, M., Turner, J., Steinman, M. A., . . . Farrell, B. (2019). Deprescribing: future directions for research. Research in social and administrative pharmacy, 15(6), 801-805.
DOI |
| 2019 |
Laroche, M. L., Sirois, C., Reeve, E., Gnjidic, D., & Morin, L. (2019). Pharmacoepidemiology in older people: purposes and future directions. Therapies, 74(2), 325-332.
DOI |
| 2019 |
Reeve, E., Farrell, B., Thompson, W., Herrmann, N., Sketris, I., Magin, P. J., . . . Hilmer, S. N. (2019). Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary. Medical journal of Australia, 210(4), 174-179.
DOI |
| 2019 |
Kroger, E., Simard, M., Sirois, M. J., Giroux, M., Sirois, C., Kouladjian O'Donnell, L., . . . Emond, M. (2019). Is the drug burden index related to declining functional status at follow-up in community-dwelling seniors consulting for minor injuries? Results from the Canadian emergency team initiative cohort study. Drugs and aging, 36(1), 73-83.
DOI |
| 2019 |
Nguyen, T. A., Gilmartin Thomas, J., Tan, E. C. K., Kalisch Ellett, L., Eshetie, T., Gillam, M., & Reeve, E. (2019). The impact of pharmacist interventions on quality use of medicines, quality of life, and health outcomes in people with dementia and/or cognitive impairment: a systematic review. Journal of Alzheimer's disease, 71(1), 83-96.
DOI Scopus27 WoS25 Europe PMC21 |
| 2019 |
Ailabouni, N. J., & Reeve, E. (2019). Can existing tools predict older adults' willingness to deprescribe? Considerations for D-PRESCRIBE's post-hoc secondary analysis. Research in Social and Administrative Pharmacy, 15(11), 1379-1380.
DOI |
| 2019 |
Jungo, K. T., Rozsnyai, Z., Mantelli, S., Floriani, C., Reeve, E., & Streit, S. (2019). 'Optimising PharmacoTherapy In the multimorbid elderly in primary CAre' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial. BMJ open, 9(9, article no. e031080), 1-12.
DOI Scopus16 Europe PMC12 |
| 2018 |
Reeve, E., Moriarty, F., Nahas, R., Turner, J. P., Kouladjian O'Donnell, L., & Hilmer, S. N. (2018). A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert opinion on drug safety, 17(1), 39-49.
DOI |
| 2018 |
Mantelli, S., Jungo, K. T., Rozsnyai, Z., Reeve, E., Luymes, C. H., Poortvliet, R. K. E., . . . Streit, S. (2018). How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study. BMC family practice, 19(1, article number 169), 1-8.
DOI |
| 2018 |
Reeve, E., Anthony, A. C., Kouladjian O'Donnell, L., Low, L. F., Ogle, S. J., Glendenning, J. E., . . . Hilmer, S. N. (2018). Development and pilot testing of the revised patients' attitudes towards deprescribing questionnaire for people with cognitive impairment. Australasian journal on ageing, 37(4), E150-E154.
DOI |
| 2018 |
Okeowo, D., Patterson, A., Boyd, C., Reeve, E., Gnjidic, D., & Todd, A. (2018). Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?. Therapeutic advances in drug safety, 9(11), 619-630.
DOI |
| 2018 |
Reeve, E., Wolff, J. L., Skehan, M., Bayliss, E. A., Hilmer, S. N., & Boyd, C. M. (2018). Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States. JAMA Internal medicine, 178(12), 1673-1680.
DOI |
| 2017 |
Reeve, E., Trenaman, S. C., Rockwood, K., & Hilmer, S. N. (2017). Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert opinion on drug metabolism and toxicology, 13(6), 651-667.
DOI |
| 2017 |
Reeve, E., Thompson, W., & Farrell, B. (2017). Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. European journal of internal medicine, 38, 3-11.
DOI |
| 2017 |
Babar, Z. U. D., Gammie, T. M., Gnjidic, D., Reeve, E., Jordan, V., Hilmer, S. N., . . . Lu, C. Y. (2017). Withdrawal of antihypertensive drugs in older people. Cochrane database of systematic reviews, 2017(2), 2-10.
DOI |
| 2017 |
Sirois, C., Ouellet, N., & Reeve, E. (2017). Community-dwelling older people's attitudes towards deprescribing in Canada. Research in social and administrative pharmacy, 13(4), 864-870.
DOI |
| 2017 |
Chan, B., Reeve, E., Matthews, S., Carroll, P. R., Long, J. C., Held, F., . . . Hilmer, S. N. (2017). Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. British journal of clinical pharmacology, 83(6), 1185-1196.
DOI |
| 2017 |
Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D. (2017). A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. European journal of clinical pharmacology, 73(8), 927-935.
DOI |
| 2017 |
Reeve, E., Molin, P., Hui, A., & Rockwood, K. (2017). Exploration of verbal repetition in people with dementia using an online symptom-tracking tool. International psychogeriatrics, 29(6), 959-966.
DOI |
| 2017 |
Wu, A., Reeve, E., Hilmer, S., & Gnjidic, D. (2017). Hospital pharmacists' beliefs about optimising statin therapy in older inpatients. Journal of pharmacy practice and research, 47(3), 223-227.
DOI |
| 2017 |
Reeve, E., & Hilmer, S. (2017). Tapering or abrupt cessation of proton pump inhibitors?. European journal of clinical pharmacology, 73(7), 923-924.
DOI |
| 2017 |
Ong, G., Page, A., Caughey, G., Johns, S., Reeve, E., & Shakib, S. (2017). Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy. Pharmacology Research and Perspectives, 5(3), 1-6.
DOI Scopus10 WoS9 Europe PMC6 |
| 2016 |
Kalogianis, M. J., Wimmer, B. C., Turner, J. P., Tan, E. C. K., Emery, T., Robson, L., . . . Bell, J. S. (2016). Are residents of aged care facilities willing to have their medications deprescribed?. Research in social and administrative pharmacy, 12(5), 784-788.
DOI Scopus62 WoS62 Europe PMC48 |
| 2016 |
Reeve, E., Low, L., Shakib, S., & Hilmer, S. (2016). Development and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs and Aging, 33(12), 913-928.
DOI Scopus163 WoS158 Europe PMC136 |
| 2016 |
Gilmartin, J. F. M., Nguyen, T. A., Reeve, E., & Tan, E. C. K. (2016). Incorporating research into current pharmacy practice: the future of Australian pharmacy?. Journal of pharmacy practice and research, 46(4), 397-398.
DOI Scopus2 |
| 2016 |
Kouladjian, L., Gnjidic, D., Reeve, E., Chen, T. F., & Hilmer, S. N. (2016). Health care practitioners' perspectives on deprescribing anticholinergic and sedative medications in older adults. Annals of pharmacotherapy, 50(8), 625-636.
DOI |
| 2016 |
Galazzi, A., Lusignani, M., Chiarelli, M. T., Mannucci, P. M., Franchi, C., Tettamanti, M., . . . Nobili, A. (2016). Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. International journal of clinical pharmacy, 38(2), 454-461.
DOI |
| 2016 |
Reeve, E., Low, L. F., & Hilmer, S. N. (2016). Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. British journal of general practice, 66(649), e552-e560.
DOI |
| 2016 |
Thai, M., Reeve, E., Hilmer, S. N., Qi, K., Pearson, S. A., & Gnjidic, D. (2016). Prevalence of statin-drug interactions in older people: a systematic review. European journal of clinical pharmacology, 72(5), 513-521.
DOI |
| 2016 |
Reeve, E., Denig, P., Hilmer, S. N., & ter Meulen, R. (2016). The ethics of deprescribing in older adults. Journal of bioethical inquiry, 13(4), 581-590.
DOI |
| 2015 |
Qi, K., Reeve, E., Hilmer, S. N., Pearson, S. A., Matthews, S., & Gnjidic, D. (2015). Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. International journal of clinical pharmacy, 37(5), 949-957.
DOI |
| 2015 |
Thai, M., Hilmer, S., Pearson, S. A., Reeve, E., & Gnjidic, D. (2015). Prevalence of potential and clinically relevant statin-drug interactions in frail and robust older inpatients. Drugs and aging, 32(10), 849-856.
DOI |
| 2015 |
Reeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. British journal of clinical pharmacology, 80(6), 1254-1268.
DOI |
| 2015 |
Reeve, E., & Turner, J. P. (2015). Patients' perspectives on the brave new word 'deprescribing'. International Journal of Pharmacy Practice, 23(1), 90-91.
DOI |
| 2015 |
Grzeskowiak, L., Thomas, A., To, J., Phillips, A., & Reeve, E. (2015). Enhancing education activities for health care trainees and professionals using audience response systems: a systematic review. Journal of Continuing Education in the Health Professions, 35(4), 261-269.
DOI Scopus23 WoS21 Europe PMC14 |
| 2015 |
Reeve, E., Wiese, M. D., & Mangoni, A. A. (2015). Alterations in drug disposition in older adults. Expert opinion on drug metabolism & toxicology, 11(4), 491-508.
DOI Scopus94 Europe PMC66 |
| 2015 |
Reeve, E., Andrews, J., Wiese, M., Hendrix, I., Roberts, M., & Shakib, S. (2015). Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Annals of Pharmacotherapy, 49(1), 29-38.
DOI Scopus76 WoS58 Europe PMC54 |
| 2015 |
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., . . . Martin, J. H. (2015). Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine, 175(5), 827-834.
DOI WoS1084 Europe PMC927 |
| 2015 |
Grzeskowiak, L., Thomas, A., To, J., Reeve, E., & Phillips, A. (2015). Enhancing continuing education activities using audience response systems: a single-blind controlled trial. Journal of Continuing Education in the Health Professions, 35(1), 38-45.
DOI Scopus15 WoS14 Europe PMC7 |
| 2015 |
Reeve, E., Gnjidic, D., & Hilmer, S. (2015). The role of the OncPal deprescribing guideline in end-of-life care. Supportive care in cancer, 23(4), 899.
DOI |
| 2015 |
Reeve, E., Bell, J. S., & Hilmer, S. N. (2015). Barriers to optimising prescribing and deprescribing in older adults with dementia: a narrative review. Current clinical pharmacology, 10(3), 168-177.
DOI |
| 2014 |
Reeve, E., Shakib, S., Hendrix, I., Roberts, M., & Wiese, M. (2014). The benefits and harms of deprescribing. Medical Journal of Australia, 201(7), 386-389.
DOI Scopus92 WoS70 Europe PMC60 |
| 2014 |
Tan, E., Visvanathan, R., Hilmer, S., Vitry, A., Quirke, T., Emery, T., . . . Bell, J. (2014). Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol. BMJ Open, 4(6), 1-6.
DOI Scopus32 WoS34 Europe PMC26 |
| 2014 |
Reeve, E., Shakib, S., Hendrix, I., Roberts, M., & Wiese, M. (2014). Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. British Journal of Clinical Pharmacology, 78(4), 738-747.
DOI Scopus302 WoS277 Europe PMC224 |
| 2014 |
Reeve, E., & Wiese, M. D. (2014). Benefits of deprescribing on patients' adherence to medications. International journal of clinical pharmacy, 36(1), 26-29.
DOI |
| 2013 |
Reeve, E., Wiese, M., Hendrix, I., Roberts, M., & Shakib, S. (2013). People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. Journal of the American Geriatrics Society, 61(9), 1508-1514.
DOI Scopus197 WoS173 Europe PMC153 |
| 2013 |
Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M., & Wiese, M. (2013). Patient barriers to and enablers of deprescribing: a systematic review. Drugs and Aging, 30(10), 793-807.
DOI Scopus415 WoS393 Europe PMC344 |
| 2013 |
Reeve, E., Shakib, S., Hendrix, I., Roberts, M., & Wiese, M. (2013). Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. International Journal of Clinical Pharmacy, 35(1), 51-56.
DOI Scopus94 WoS89 Europe PMC83 |
| 2012 |
Reeve, E., & Wiese, M. D. (2012). Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderly. Drugs & aging, 29(11), 925-926.
DOI |
